Samir N. Khleif, MD

Oncologist, Immuno-Oncology Scientist, Health Care Transformational Leader- Biomedical Scholar and professor Lombardi Cancer Center, Georgetown University

[Daniel Powell Lab @ UPENN @DJPowellLab]

@michaelbriskin @Chrystal_Paulos @3PSolution @FondMelanoma @sitcancer Done! Margarita Pizza x 3.
One at its birthplace with guru and pizza aficionado @SamirNKhleif.

[Bernard A Fox @BernardAFox]

GREAT DEBATE 1: Can computational biology improve clinical trial design? Dr Robert Beckman says NO! Dr. @SamirNKhleif says YES! Both from @Georgetown #Bridge2022 Key word is Can! PROF KHLEIF WINS - 100% convinced @FondMelanoma @PAscierto

[Samir N. Khleif, MD @SamirNKhleif]

Amazing group of experts @NASEM National Cancer Policy Forum planning an enhanced path for the immunotherapy filed - outcome to follow

[Jason Luke, MD, FACP, FASCO @jasonlukemd]

Fabulous mtg @theNASEM Addressing Resistance in the Development of Cancer Immune Modulator Therapeutics: A Workshop. Tx @SamirNKhleif @weinerg for organizing! It’s a 2 day meeting & link is live - join us!
https://t.co/83WRAk0iKa

[Hussein Tawbi, MD, PhD @HTawbi_MDPhD]

So good to be with good friends ⁦@EladSharonMD⁩ & colleagues Jane Healy MD, ⁦@theNASEM⁩ for “Addressing Resistance to Immune Modulators in Cancer Workshop” thanks ⁦⁦@SamirNKhleif⁩ for the invite- hope we can contribute to accelerating IO drug development!

[Elad Sharon @EladSharonMD]

@HTawbi_MD @theNASEM @SamirNKhleif Amazing space @theNASEM and some incredibly talented, thoughtful, and dedicated researchers! Thanks so much to the organizers for including me!

[Dr. Paul De Santis, PharmD @DrPaulyDeSantis]

@EladSharonMD @HTawbi_MD @theNASEM @SamirNKhleif You stole my tweet, beautiful architecture was going to ask where… but you solved the mystery

[Usama Fayyad @usamaf]

Wanted to thank @SamirNKhleif for co-organizing the workshop at @theNASciences & taking the photo - the #AI+#LifeSciences at @Experiential_AI @Northeastern @svscarpino https://t.co/vOxMiKsLq9

[Usama Fayyad @usamaf]

Great to meet in person @SamirNKhleif at the @theNASciences - thanks for panel photo in the post: https://t.co/ZCaL6N3l8z - looking forward to workshop summary/recommendations, implications for #ai + #lifesciences at @Experiential_AI @Northeastern - @svscarpino

[Bernard A Fox @BernardAFox]

Very sad 2 be virtual 4 @PAscierto’s #melanoma bridge/will miss being in room 4 great debates! I will be online 4 all of it @PaulosLab @OmidHamidMD @SamirNKhleif @jasonlukemd @MandalaMario @JeromeGalon @mcquadeMDLAc @KunleOdunsiMD @ProfGLongMIA @NicolaNormanno @AlfredoBudillon

[Healthcare Hashtag Project @healthhashtags]

Top Influencers of #sitc21: @sitcancer @JennGuerriero @SamirNKhleif @ChilesResearch @blhorton @DrLizJaffee More 📊 https://t.co/IAF4nGviy2

[Samir N. Khleif, MD @SamirNKhleif]

Dr Kald Abdalla presenting alternative strategies for combination therapy @bmsnews great insight @sitcancer #sitc #SITC2021 #SITC

[Osama Rahma @OsamaRahma2]

Unfortunately I have to present virtually but still with lot of excitement #SITC21
join us for a debate on novel trial design to replace 3+3 dose escalation design for #Immunotherapy trials @SamirNKhleif @Joshua_Reuss

[Samir N. Khleif, MD @SamirNKhleif]

@danasma70194694 Congrats!!

[Samir N. Khleif, MD @SamirNKhleif]

Amazing talk from Ben Youngblood @cityofhope about redesigning CAR-T strategy taking advantage of inhibiting exhaustion - part of the Immune Resistance Symposium @sitcancer #sitc #SITC21 #sitc2021

[Samir N. Khleif, MD @SamirNKhleif]

John Wherry @PennMEHP describes new understanding of T cell exhaustion biology and anti-PD1 therapy - great insight @sitcancer #SITC21 #SITC #sitc

[Samir N. Khleif, MD @SamirNKhleif]

At the Immune Resistance Symposium J Louise Lines discusses The role of VISTA in resistance @sitcancer very informative! #SITC21 #sitc

[Samir N. Khleif, MD @SamirNKhleif]

Vijay Kuchroo discussed the latest in TIM3 targeting at the Immune Resistance Symposium. Great talk @sitcancer @DanaFarber #SITC21 #sitc #SITC #sitc2021

[Samir N. Khleif, MD @SamirNKhleif]

Andy Weinberg giving a very informative talk on anti-OX40 an agent that has a biiig potential if used properly- should not be missed. Great scientist! @sitcancer @ChilesResearch #SITC21 #sitc2021

[David Braun @BraunMDPhD]

@SamirNKhleif from @Georgetown highlighting the importance of optimally priming T cells BEFORE PD-1 blockade. If the T cells are suboptimal primed, PD-1 blockade may actually induce T cell dysfunction #SITC21